Valaciclovir Impurity A :
2-Amino-1,9-dihydro-6H-purin-6-one ; CAS : 73-40-5 ; C5H5N5O ; MW: 151.13 ; |
Valaciclovir Impurity B:
2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one ; CAS : 59277-89-3 ; C8H11N5O3 ; MW: 225.20 ; |
Valaciclovir Impurity C:
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl-N-methyl-L-valinate ; CAS : 1346617-39-7 (HCl salt) ; 1346747-65-6 (base) ; C14H22N6O4 (base) ; MW: 338.36 ; C14H23ClN6O4 (HCl salt) ; MW: 374.82 ; |
Valaciclovir Impurity D :
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl-N-ethyl-L-valinate ; CAS : 1346747-69-0 ; C15H24N6O4 ; MW: 352.39 ; |
Valaciclovir Impurity E:
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-(benzyloxy carbonyl)-L-valinate ; CAS : 124832-31-1 ; C21H26N6O6 ; MW: 458.47 ; |
Valaciclovir Impurity F :
2-Hydroxyethyl L-valinate tosylate ; CAS : 86150-61-0 ; C14H23NO6S ; MW: 333.40 ; |
Valaciclovir Impurity G:
N,N-Dimethylpyridin-4-amine ; CAS : 1122-58-3 ; C7H10N2 ; MW: 122.17 ; |
Valaciclovir Impurity H:
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-alaninate ; CAS : 84499-64-9 (base) ; 84499-63-8 (HCl salt) ; C11H16N6O4 ; MW: 296.28 ; |
Valaciclovir Impurity I:
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl acetate ; CAS : 102728-64-3 ; C10H13N5O4 ; MW: 267.24 ; |
Valaciclovir Impurity J:
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl L-isoleucinate ; CAS : 142963-63-1 ; C14H22N6O4 ; MW: 338.36 ; |
Valaciclovir Impurity K:
9-[(2-Hydroxyethoxy)methyl]-2-[[[(6-oxo-6,9-dihydro-1Hpurin-2-yl) amino] methyl]amino]-1,9-dihydro-6H-purin-6-one ; C14H16N10O4 ; MW: 388.34 ; |
Valaciclovir Impurity L:
2,2′-(Methylenediimino)bis[9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one] ; CAS : 1797131-64-6 ; C17H22N10O6 ; MW: 462.42 ; |
Valaciclovir Impurity M:
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-formyl-L-valinate ; CAS : 847670-62-6 ; C14H20N6O5 ; MW: 352.35 ; |
Valaciclovir Impurity N :
2-[[6-Oxo-2-[[[(6-oxo-6,9-dihydro-1H-purin-2-yl)amino]methyl]amino]-1,6-dihydro-9H-purin-9-yl]methoxy]ethyl L-valinate ; C19H25N11O5 ; MW: 487.47 ; |
Valaciclovir Impurity O:
2-[[2-[[[[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl] amino] methyl]amino]-6-oxo-1,6-dihydro-9H-purin-9-yl]methoxy]ethyl L-valinate ; C22H31N11O7 ; MW: 561.55 ; |
Valaciclovir Impurity P:
2,2′-[Methylenebis[imino(6-oxo-1,6-dihydro-9H-purine-9,2-diyl)methylene oxy]] diethyl di(L-valinate) ; CAS :1356019-51-6 ; C27H40N12O8 ; MW: 660.68 ; |
Valaciclovir Impurity Q:
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl N-[[(6-oxo-6,9-dihydro-1H-purin-2-yl)amino]methyl]-L-valinate ; C19H25N11O5 ; MW: 487.47 ; |
Valaciclovir Impurity R :
2-[(2-Amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy]ethyl D-valinate hydrochloride ; CAS : 124832-28-6 ; C13H21ClN6O4 ; MW: 360.8 ; |